Clinicoepidemiological manifestations of RPGN and ANCA-associated vasculitides: an 11-year retrospective hospital-based study in Japan

References

• Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337 :1512–23.
   PubMed Web of Science ®Google Scholar
• Haugeberg G, Bie R, Bendvold A, Larsen AS, Johnsen V. Pri-mary vasculitis in a Norwegian community hospital: a retro-spective study. Clin Rheumatol. 1998;17:364–8.
   Google Scholar
• Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum. 2000;43:414–9.
   PubMed Web of Science ®Google Scholar
• Watts RA, Scott DG, Jayne DRW, Ito-Ihara T, Muso E, Fujimoto S, et al. Renal vasculitis in Japan and UK—are there differences in epidemiology and clinical phenotype? Nephrol Dial Trans-plant. 2008,23(12) : 3743–5.
   Google Scholar
• Lane SE, Scott DG, Heaton A, Watts RA. Primary renal vasculitis in Norfolk-increasing incidence or increasing recognition? Nephrol Dial Transplant. 2000;15:23–7.
   Google Scholar
• Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum. 2005;53:93–9.
   Google Scholar
• Fujimoto S, Uezono S, Hisanaga S, Fukudome K, Kobayashi S, Suzuki K, et al. Incidence of ANCA-associated primary renal vasculitis in Miyazaki prefecture: the first population-based, retro-spective, epidemiologic survey in Japan. Clin J Am Soc Nephrol. 2006;1:1016–22.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Inaba Y, Nakayama T, et al. Nationwide epidemio-logical survey of refractory vasculitis (anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, anti-phospholipid syn-drome and temporal arteritis) in Japan. Annual report of the research committee on intractable vasculitides, Ministry of Health and Wel-fare of Japan [in Japanese], Tokyo. 1998. p. 15–23.
   Google Scholar
• Sakai H, Kurokawa K, Koyama A, Arimura Y, Kida H, Shig-ematsu H, et al. Committee for the Guidelines on Diagnosis and Therapy of Rapidly Progressive Glomerulonephritis: guidelines for the management of rapidly progressive glomerulonephritis [in Japanese]. Jpn J Nephrol. 2002;44:55–82.
   Google Scholar
• Yamagata K, Hirayama K, Mase K, Yamaguchi N, Kobayashi M, Takahashi H, et al. Apheresis for MPO-ANCA-associated RPGN-indications and efficacy: lessons learned from Japan Nationwide survey of RPGN. J Clin Apheresis. 2005;20:244–51.
   PubMed Web of Science ®Google Scholar
• Koyama A, Yamagata K, Makino H, Ariyama Y, Wada T, Nitta K, et al. A nationwide survey of rapidly progressive glomerulo-nephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009 (Epub ahead of pub).
   Google Scholar
• Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, Rodriguez-Ledo P, Llorca J. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Con-ference definitions. Arthritis Rheum. 2003;49:388–93.
   PubMed Web of Science ®Google Scholar
• Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, et al. Pan-Thames Renal Research Group: outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003;41:776–84.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Xiao H, Falk RJ. Pathogenesis of vascular inflam-mation by anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol. 2006;17:1235–42.
   Google Scholar
• Kallenberg CG, Heeringa P, Stegeman CA. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vas-culitides. Nat Clin Pract Rheumatol. 2006;2:661–70.
   PubMedGoogle Scholar
• Morgan MD, Harper L, Williams J, Savage C. Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol. 2006;17 :1224–34.
   PubMed Web of Science ®Google Scholar
• van Paassen P, Cohen Tervaert JW, Heeringa P. Mechanisms of vasculitis: how pauci-immune is ANCA-associated renal vascu-litis? Nephron Exp Nephrol. 2007;105:e10–6.
   Google Scholar
• Satchell SC, Nicholls AJ, D'Souza RJ, Beaman M. Renal vas-culitis: increasingly a disease of the elderly? Nephron Clin Pract. 2004;97:c142–6.
   Google Scholar
• Levy JB, Winearls CG. Rapidly progressive glomerulonephritis: what should be first-line therapy? Nephron. 1994;67:402–7.
   Google Scholar
• Haas M, Spargo BH, Wit EJ, Meehan MJ. Etiologies and out-come of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. Am J Kidney Dis. 2000;35:433–47.
   PubMed Web of Science ®Google Scholar
• Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noel LH, Waldherr R, et al. European Vasculitis Study Group (EU-VAS). Renal histology in ANCA-associated vasculitis: differ-ences between diagnostic and serologic subgroups. Kidney Int. 2002;61:80–9.
   Google Scholar
• Tsuchiya N, Kobayashi S, Kawasaki A, Kyogoku C, Arimura Y, Yoshida M, et al. Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of HLA-DRB1*0901 with microscopic polyangiitis. J Rheumatol. 2003;30:1534–40.
   PubMed Web of Science ®Google Scholar
• Yashiro M, Muso E, Itoh-lhara T, Oyama A, Hashimoto K, Kawamura T, et al. Significantly high regional morbidity of MPO-ANCA-related angitis and/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan). Am J Kidney Dis. 2000;35: 889–95.
   Google Scholar
• Ito-lhara T, Muso E, Kobayashi S, Uno K, Tamura N, Yamashita Y, et al. A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe. Clin Exp Rheumatol. 2008;26:1027–33.
   Google Scholar
• Couser WG. Rapidly progressive glomerulonephritis: classifica-tion, pathogenetic mechanisms, and therapy. Am J Kidney Dis. 1998;11:449–64.
   Google Scholar
• Angangco R, Thiru S, Esnault VL, Short AK, Lockwood CM, Oliveira DB. Does truly 'idiopathic' crescentic glomerulone-phritis exist? Nephrol Dial Transplant. 1994;9:630–6.
   Google Scholar
• Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63:1164–77.
   PubMed Web of Science ®Google Scholar
• Jayne D, Rasmussen N, Andrassy K, Bacon C, Tervaert JW, Dadoniene D, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoan-tibodies. N Engl J Med. 2003;349:36–44.
   PubMed Web of Science ®Google Scholar
• Jayne DR, Gaskin G, Rasmussen N, Abramowicz D, Ferrario F, Guillevin L, et al. European Vasculitis Study Group: randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol. 2007;18:2180–8.
   PubMed Web of Science ®Google Scholar